A clinical trial to study the effect of Unani drug in the treatment of liver cirrhosis.

Phase 2

• Conditions: Health Condition 1: K740- Hepatic fibrosis

• Registration Number: CTRI/2021/09/036474
• Lead Sponsor: Deptt of Moalajat School of Unani Medical Education and Research Jamia Hamdard University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: ot Applicable
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Radiological ( Elastography: Metavir score � f4(i.e. more than 12kPa) evidence of liver cirrhosis

Child-turcotte-Pugh Score A and B

Exclusion Criteria

Pregnant women and lactating mothers

Mentally retarded patients

Patients who failed to give informed consent

Patient with Hepatic Encephalopathy

Patients with comorbid heart and kidney disease

History of active bleeding

Severe bacterial infection

History of malignancy

Patient whose CHILD PUGH score lies in category C

Uncontrolled Diabetes Mellitus

Study & Design

• Study Type: Interventional
• Study Design: Not specified